1. Home
  2. DNA vs MLAB Comparison

DNA vs MLAB Comparison

Compare DNA & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNA
  • MLAB
  • Stock Information
  • Founded
  • DNA 2008
  • MLAB 1982
  • Country
  • DNA United States
  • MLAB United States
  • Employees
  • DNA N/A
  • MLAB N/A
  • Industry
  • DNA Biotechnology: Biological Products (No Diagnostic Substances)
  • MLAB Industrial Machinery/Components
  • Sector
  • DNA Health Care
  • MLAB Industrials
  • Exchange
  • DNA Nasdaq
  • MLAB Nasdaq
  • Market Cap
  • DNA 529.8M
  • MLAB 441.2M
  • IPO Year
  • DNA N/A
  • MLAB N/A
  • Fundamental
  • Price
  • DNA $8.01
  • MLAB $73.67
  • Analyst Decision
  • DNA Strong Sell
  • MLAB Hold
  • Analyst Count
  • DNA 1
  • MLAB 1
  • Target Price
  • DNA $9.00
  • MLAB $67.00
  • AVG Volume (30 Days)
  • DNA 1.3M
  • MLAB 100.5K
  • Earning Date
  • DNA 11-06-2025
  • MLAB 11-06-2025
  • Dividend Yield
  • DNA N/A
  • MLAB 0.87%
  • EPS Growth
  • DNA N/A
  • MLAB N/A
  • EPS
  • DNA N/A
  • MLAB N/A
  • Revenue
  • DNA $180,606,000.00
  • MLAB $245,255,000.00
  • Revenue This Year
  • DNA N/A
  • MLAB $5.38
  • Revenue Next Year
  • DNA $14.41
  • MLAB $5.25
  • P/E Ratio
  • DNA N/A
  • MLAB N/A
  • Revenue Growth
  • DNA N/A
  • MLAB 7.39
  • 52 Week Low
  • DNA $5.00
  • MLAB $55.45
  • 52 Week High
  • DNA $17.58
  • MLAB $155.12
  • Technical
  • Relative Strength Index (RSI)
  • DNA 27.83
  • MLAB 46.86
  • Support Level
  • DNA $8.27
  • MLAB $70.00
  • Resistance Level
  • DNA $13.18
  • MLAB $82.37
  • Average True Range (ATR)
  • DNA 0.74
  • MLAB 4.39
  • MACD
  • DNA -0.47
  • MLAB -0.25
  • Stochastic Oscillator
  • DNA 6.46
  • MLAB 29.18

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

Share on Social Networks: